Skip to main content Accessibility help
×
Home
Hostname: page-component-544b6db54f-rcd7l Total loading time: 0.398 Render date: 2021-10-16T12:07:11.706Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Capacity to consent to treatment in patients with acute mania

Published online by Cambridge University Press:  02 January 2018

Jonathan Beckett
Affiliation:
South London and Maudsley NHS Trust, Lambeth Hospital, London
Robert Chaplin
Affiliation:
College Research Unit, Royal College of Psychiatrists, London, and Oxfordshire Mental Healthcare NHS Trust, Littlemore Hospital, Oxford, email: rchaplin@cru.rcpsych.ac.uk
Rights & Permissions[Opens in a new window]

Abstract

Aims and Method

This study aimed to determine the proportion of patients hospitalised with mania who had capacity to consent to treatment, to determine the predictors of capacity and to explore the relationship between detained status and capacity. Fifty in-patients with mania participated in a clinical interview to assess capacity.

Results

Nineteen patients (38%) had overall capacity. Capacity was predicted by higher IQ, lower severity of manic symptoms and more episodes of depression; it was not related to voluntary or detained status. The domains of capacity were not hierarchical.

Clinical Implications

Many patients hospitalised with mania have capacity to make an informed choice regarding treatment even when compulsorily detained. Their capacity should be reviewed frequently and measures adopted to enhance capacity.

Type
Original papers
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 2006

The involvement of people with mental illness in making decisions about their treatment is becoming increasingly important. This principle is highlighted both in the guidelines issued by the National Institute for Clinical Excellence (2002) and in the revised Draft Mental Health Bill (Department of Health, 2004). However, the ability to collaborate in treatment decisions depends upon the person’s capacity and this is frequently adversely affected by the presence of mental illness. The capacity of patients with schizophrenia has been extensively studied and has shown a broad range, from significantly impaired to full capacity in both the acute (Reference GellerGeller, 1982; Reference Grisso and AppelbaumGrisso & Appelbaum, 1995) and chronic (Reference Eastwood and PughEastwood & Pugh, 1997) stages of the illness. In-patients with depression have shown relatively unimpaired capacity (Reference Grisso and AppelbaumGrisso & Appelbaum, 1995). Patients with bipolar disorder have not been studied.

This study had the primary aim of determining the proportion of hospitalised patients with acute mania who had capacity to consent to acute drug treatment. Secondary aims were to investigate the factors that predict whether a patient has capacity, to explore the relationship between detained status and capacity to consent to treatment and to investigate whether there is a hierarchical relationship between the domains of capacity.

Method

In-patients with an ICD-10 (World Health Organization, 1992) diagnosis of bipolar affective disorder, current episode manic with or without psychosis, were recruited from a psychiatric hospital. All in-patients aged 18-75 years with a possible diagnosis of mania from case notes were assessed for eligibility by one of two specialist registrars in psychiatry. The diagnosis was confirmed by reference to the case notes and following discussion with the clinical team. Patients with an unclear diagnosis, a diagnosis of schizoaffective disorder or those predicted to have a low Young Mania Rating Scale score (YMRS; Reference Young, Biggs and ZieglerYoung et al, 1978) were excluded. Patients were approached during the first few days of admission and those unable to give informed consent to enter the study were approached at a later date after clinical improvement.

Each patient was interviewed by a specialist registrar. Initially, the YMRS was administered and those scoring 20 or more proceeded with the rest of the interview. Administration of the National Adult Reading Test (NART; Reference NelsonNelson, 1982) yielded a premorbid estimation of IQ. From this interview (and from perusal of the case notes) the following data were obtained: basic demographic details; voluntary or detained status; length of illness; number of illness episodes; alcohol (units) and illicit substances consumed in the week preceding admission; and educational level achieved.

Each patient’s capacity to consent to their treatment was assessed using a clinical interview based on the definition of capacity as laid out in the Code of Practice of the Mental Health Act 1983 (Department of Health, 1999) and the British Medical Association and Law Society Guidelines (British Medical Association & Law Society, 1995). The assessment was designed to give a global judgement of capacity based on a clinical interview. Personalised information about diagnosis, treatment and its risks and benefits was initially disclosed to the patient. The following information was disclosed: three prominent features of the illness, one current medication (preferably a mood stabiliser) and two current (or potential) side-effects experienced by the patient.

Capacity was then assessed along four separate domains. These domains were:

  1. (a) The ability to retain the information given to them in the disclosure. Patients had to recall at least two out of three features of the illness, the medication they were taking and one of the two possible side-effects given in the disclosure.

  2. (b) The ability to understand the information disclosed relevant to making a decision about treatment. To assess this domain, the following questions relating to the disclosure were asked: ‘Do you believe that this situation relates to you?’,‘To what extent does it apply to you?’and ‘What do you understand of your situation?’.

  3. (c) The ability to reason, to weigh up the information in the balance as part of a process of arriving at a decision about their treatment. To assess this domain, the following questions relating to the disclosure were asked: ‘What effect do you think the treatment will have on you?’,‘If you stopped your medication, what do you think might happen?’, Have you thought about alternative treatments? If so, what?’

  4. (d) The ability to communicate a decision about treatment. The following question was asked to assess this domain:‘Now that we’ve had a discussion about your treatment, are you happy to stay on your medication?’

Initially we included an additional domain, relating to patients’ ability to believe that the information disclosed applied to them. This domain was later removed from our study, as it was not included in the definition of capacity laid out in the new Mental Capacity Act (Department for Constitutional Affairs, 2005). Patients with capacity in all domains were defined as having overall capacity. Interview transcripts of the capacity assessments made by one of the two specialist registrars were assessed by a consultant psychiatrist (R.C.) who was unaware of the identity of the interviewer and interviewee, and the percentage agreement and interrater reliability between these assessments were calculated.

Data were entered onto the Statistical Package for the Social Sciences (SPSS) version 9.0 for Windows. χ2 and independent-samples t-tests were used to investigate the relationships between capacity and categorical and continuous variables respectively. A logistic regression analysis was employed to confirm independent predictors of capacity and to eliminate the confounding effects of variables.

Results

Initially a total of 93 patients were considered for entry into the study, of whom 26 were ineligible (12 did not have mania and 14 were considered to be in an insufficiently manic state). Fifty (75%) of the 67 eligible patients completed the interview (Fig. 1). Agreement between clinicians was reached on 86% of the 200 items of capacity (κ=0.68, 95% CI 0.57-0.79). Nineteen of the 50 patients (38%) were found to have overall capacity (Table 1).

Table 1. Patients with capacity according to domain and overall rating

Patients with capacity Patients without capacity
Domain of capacity n % (95% CI) n % (95% CI)
Retain 32 64 (51-77) 18 36 (23-49)
Understand 22 44 (30-58) 28 56 (42-70)
Weigh up 33 67 (54-80) 17 33 (20-46)
Communicate a choice 49 98 1 2
Overall capacity 19 38 (22-51) 31 62 (49-75)

The three domains of capacity were significantly related to each other: retain/understand, χ2=12.347, P<0.001; retain/weigh up, χ2=22.727, P<0.001; understand/weigh up χ 2=10.080, P=0.001. There was no relationship between capacity and voluntary or detained status (χ2=0.801, P=0.37), with approximately equal numbers of both groups of patients having capacity. Univariate analysis (Table 2) showed that capacity was predicted by prescription of a mood stabiliser, greater number of depressive episodes, lower YMRS score and higher IQ.

Table 2. Clinical and demographic associations with capacity

Variable All patients Patients with capacity Statistical test P
Gender, n (%)
     Male 24 (48) 9 (38) χ 2=0.005 0.94
     Female 26 (52) 10 (38)
Current mood stabiliser, n (%) 33 (66) 16 (49) χ 2=4.5 0.033
Current use of illicit drugs, n (%) 12 (24) 3 (25) χ 2=1.1 0.29
Alcohol, n (%)
     None 29 (60) 11 (38) χ 2=1.6 0.46
     Below recommended limit 10 (21) 5 (50)
     Above recommended limit 9 (19) 2 (22)
Education, n (%)
     No GCSEs 7 (15) 2 (29) χ 2=1.3 0.72
     GCSEs 15 (31) 7 (47)
     A Level 13 (27) 4 (31)
     Higher education 13 (27) 6 (46)
Previous manic episodes, n (%)
     None 4 (8) 0 χ 2=3.0 0.22
     1-5 17 (35) 8 (47)
    > 5 27 (56) 11 (41)
Previous depressive episodes, n (%)
     None 21 (47) 2 (10) 0.001
     1-5 16 (36) 10 (63)
    > 5 8 (18) 5 (63)
Detained, n (%)
     Yes 33 (66) 14 (42) χ 2=0.81 0.37
     No 17 (34) 5 (29)
Age, years: mean (s.d.) 42 (13) 42 (12) t(50)=0.066 0.95
YMRS score: mean (s.d.) 29.0 (7.0) 25.5 (5.4) t(48)=2.9 0.005
IQ: mean (s.d.) 109 (10) 114 (7.5) t(38)=2.8 0.008
Length of illness, years: mean (s.d.) 16.1 (10.4) 16.3 (8.4) t(50)=0.074 0.94

Logistic regression analysis found the following variables to be independent predictors of capacity:

  1. (a) increasing numbers of depressive episodes: for one to five depressive episodes the odds ratio was 82.2 (95% CI1.83-3695.0); for more than five depressive episodes, OR=878.4 (95% CI 2.76-279835.9);

  2. (b) lower YMRS scores: OR=0.65 (95% CI 0.44-0.96);

  3. (c) higher IQ scores: OR=1.25 (95% CI1.02-1.52).

Fig. 1. Flow of participants through the study (YMRS, Young Mania Rating Scale).

Prescription of a mood stabiliser was no longer a predictor of capacity. Owing to the small number of patients in each category of number of depressive episodes, the odds ratios here are not well estimated, highlighted by their magnitude and the width of the confidence intervals. In a separate analysis the correlation between number of depressive episodes and length of illness was not significant (Spearman’s r=0.227, P=0.143).

Discussion

This study is the first to our knowledge that assesses capacity in patients with mania. It has a high inclusion rate, including the participation of a high proportion of severely unwell patients detained under the Mental Health Act. The main limitation of the study was the reliance on a clinical interview rather than the use of a standardised instrument for the assessment of capacity. The interview used to assess capacity was based on two main sources: the Code of Practice of the Mental Health Act 1983 (Department of Health, 1999) and the guidance published by the British Medical Association and the Law Society (British Medical Association & Law Society, 1995). A psychiatric interview by an experienced psychiatrist based on the above tests is at present the gold standard assessment of capacity in the UK. This study would have been strengthened by the co-administration of a structured assessment, for example the MacArthur Competence Assessment Tool for Treatment (Reference Grisso, Appelbaum and HillfotouhiGrisso et al, 1997).

In our study, although the capacity scores obtained in each domain were significantly related to one another, there was no evidence that the relationship between the domains was a hierarchical one. In practice this means there was no support for the concept that some domains of capacity are more basic than others, being relatively preserved, whereas others are more likely to be lost in individuals with more severe illness. Nearly all patients were able to communicate a choice, so this domain was not in any way discriminatory in the overall capacity assessment.

The finding that higher IQ predicted capacity suggests that intellectual ability is important in the ability to manipulate information about treatment. The inverse relationship between capacity and severity of mental illness has been further strengthened by this study. We found that increasing severity of manic symptoms predicted reduced capacity in patients with mania, a similar finding to that in schizophrenia, where severity of symptoms was related to reduced capacity (Reference Grisso and AppelbaumGrisso & Appelbaum, 1995). It is unclear from our research which specific symptoms, for example delusions or conceptual disorganisation, have the greatest negative impact on capacity. The relationship between increased previous depressive (but not manic) episodes and the presence of capacity is more difficult to explain. One possible reason is the role of insight but this needs further investigation. Insight is predictive of capacity (Reference Cairns, Maddock and BuchananCairns et al, 2005) and may be linked with the tendency to develop depressive episodes in patients with bipolar disorder (Reference GonzalesGonzales, 2005).

This study showed that there was no relationship between a patient’s capacity to consent to acute drug treatment and that patient’s status in hospital as voluntary or detained. This implies that in our patient sample capacity had either not been assessed or had not influenced the clinicians’ decision to detain the patient compulsorily. This is in line with current mental health legislation in England and Wales, the Mental Health Act 1983, which is based on a ‘status’ test and a risk assessment rather than an assessment of capacity. This contrasts with the assessment of capacity required when considering the use of common law to treat patients with a physical disorder. It has been argued that there is no ethical justification for having separate and legally discriminatory legislation for those requiring treatment for a mental rather than a physical disorder (Reference Eastman and DharEastman & Dhar, 2000). Szmukler & Holloway (Reference Szmukler and Holloway2000) argued that a capacity test should form the basis of a decision to detain patients with mental disorder and that many clinicians would favour a new Mental Health Act based on capacity. Applying mental health legislation that included a capacity clause to the patients in this study would potentially have led to some additional patients being detained, treated compulsorily and afforded rights of appeal, and some of the detained patients not being detained at all.

In conclusion, this study found that less than half of in-patients with mania had capacity to consent to treatment and that their capacity was unrelated to informal or detained status. The capacity of patients with mania should be regularly reviewed and measures should be adopted to enhance it. Further research is needed to establish the clinical utility of standardised capacity assessment in this group, and to compare the capacity of patients with mania with other clinical groups.

Acknowledgements

We thank Dr Sasha Francis who helped in recruiting patients and conducting some of the capacity interviews and Sarah White for her assistance in the statistical analysis of the data.

References

Britishmedical Association & Law Society (1995) Assessment of Mental Capacity: Guidance for Doctors and Lawyers. London: BMA.Google Scholar
Cairns, R., Maddock, C., Buchanan, A., et al (2005) Prevalence and predictors of mental incapacity in psychiatric in-patients. British Journal of Psychiatry, 187, 379385.CrossRefGoogle ScholarPubMed
Department for Constitutional Affairs (2005) Mental Capacity Act. http://www.dca.gov.uk/menincap/legis.htm Google Scholar
Department of Health (1999) Code of Practice to the Mental Health Act (1983). London: TSO (The Stationery Office).Google Scholar
Department of Health (2004). Improving Mental Health Law. Towards a New Mental Health Act. London: TSO (The Stationery Office).Google Scholar
Eastman, N. & Dhar, R. (2000) The role and assessment of mental incapacity: a review. Current Opinion in Psychiatry, 13, 557561.CrossRefGoogle Scholar
Eastwood, N. & Pugh, R. (1997) Long-term medication in depot clinics and patients' rights: an issue for assertive outreach. Psychiatric Bulletin, 21, 273275.CrossRefGoogle Scholar
Geller, J. L. (1982) State hospital patients and their medication: do they know what they take? American Journal of Psychiatry, 139, 611615.Google ScholarPubMed
Gonzales, V. (2005) Association between suicide attempts and insight among individuals with serious mental illness. Dissertation Abstracts International: The Sciences and Engineering, 65, 5399.Google Scholar
Grisso, T. & Appelbaum, P. S. (1995) The MacArthur Treatment Competent Study. III Abilities of patients to consent to psychiatric and medical treatments. Law and Human Behaviour, 19, 149174.CrossRefGoogle ScholarPubMed
Grisso, T., Appelbaum, P. S. & Hillfotouhi, C. (1997) The MacCAT–T: a clinical tool to assess patients' capacities to make treatment decisions. Psychiatric Services, 48, 14151419.Google ScholarPubMed
National Institute for Clinical Excellence (2002) Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Clinical Guideline 1. London: NICE.Google Scholar
Nelson, H. (1982) National Adult Reading Test (NART): Test Manual. Windsor: nfer Nelson.Google Scholar
Szmukler, G. & Holloway, F. (2000) Reform of the Mental Health Act: health or safety? British Journal of Psychiatry, 177, 196200.CrossRefGoogle ScholarPubMed
World Health Organization (1992) Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD–10). Geneva: WHO.Google Scholar
Young, R. C., Biggs, J.T. & Ziegler, V. E. (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429435.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Patients with capacity according to domain and overall rating

Figure 1

Table 2. Clinical and demographic associations with capacity

Figure 2

Fig. 1. Flow of participants through the study (YMRS, Young Mania Rating Scale).

Submit a response

eLetters

No eLetters have been published for this article.
You have Access
Open access
8
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Capacity to consent to treatment in patients with acute mania
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Capacity to consent to treatment in patients with acute mania
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Capacity to consent to treatment in patients with acute mania
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *